Japan Intellectual Property Rights: RECOMBINANT VIRUS PRODUCTS AND METHODS FOR INHIBITING EXPRESSION OF DYSTROPHIA MYOTONICA PROTEIN KINASE AND/OR INTERFERING WITH TRINUCLEOTIDE REPEAT EXPANSION IN 3'-UNTRANSLATED REGION OF DMPK GENE

Japan, Oct. 5 -- RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL has got intellectual property rights for 'RECOMBINANT VIRUS PRODUCTS AND METHODS FOR INHIBITING EXPRESSION OF DYSTROPHIA MYOTONICA PROTEIN KINASE AND/OR INTERFERING WITH TRINUCLEOTIDE REPEAT EXPANSION IN 3'-UNTRANSLATED REGION OF DMPK GENE.' Other related details are as follows:

Application Number: JP,2024-083610

Category (FI): A61K35/76,A61K35/761,A61K35/763,A61K48/00,A61P21/04,C12N15/113,130@Z,C12N15/861@Z,C12N15/864,100@Z,C12N15/867@Z,C12N15/86@Z

Stage: Grant (IP right granted following substantive examination.)

Filing Date: May 22, 2024

Publication Date: Aug. 6, 2024

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication.